Lobbying Filing Details
Total Spending
$50,000
Activities
1
Lobbyists
2
Gov't Entities
2
Filing Information
- Filing UUID:
87255bf2-90b3-4739-b8b5-dd13c26d6f12- Type:
- Q4 - 4th Quarter - Report
- Period:
- 2025 - 4th Quarter (Oct 1 - Dec 31)
- Date Posted:
- January 20, 2026 at 3:30 PM
- Income:
- $50,000
- Expenses:
- $0
- Document URL:
- View Submission
Quick Info
- Document Type: text/html
- Posted By: Brian Pomper
Registrant
AKIN GUMP STRAUSS HAUER & FELD
Law firm
WASHINGTON, District of ColumbiaClient
KYVERNA THERAPEUTICS, INC.
Biopharmaceutical company focused on developing cell therapies for autoimmune diseases.
California, United States of AmericaLobbying Activities (1)
Activity 1
Health IssuesIssues related to developing cell therapies for patients, including Stiff Person Syndrome, rare disease, and multiple sclerosis.
Lobbyists (2)
- ANNA ABRAM
- KANDIS MCCLURE
Government Entities (2)
- SENATE
- HOUSE OF REPRESENTATIVES